| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |